Effect | Decrease |
Trial Design | Double blind |
Trial Length | n/a |
Number of Subjects | 39 |
Sex | n/a |
39 post menopausal women were assigned to trans-resveratrol supplementation at 10 or 100mg daily (in two divided doses).
Methylation levels of the RASSF-1α gene decreased, and via decreased PGE(2) levels seemed to be a mechanisms of breast cancer risk reduction.